Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
10/12/2006 | WO2005105978A3 Drying process for preserving an active agent as a highly viscous liquid |
10/12/2006 | WO2005097200A3 Tetanus toxin fusion protein for visualization of active synapses |
10/12/2006 | WO2005012479A3 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
10/12/2006 | US20060229706 Drug-Delivery Endovascular Stent and Method for Treating Restenosis |
10/12/2006 | US20060229359 Tocopherol-modified therapeutic drug compounds |
10/12/2006 | US20060229331 Ketoprofen compositions and methods of making them |
10/12/2006 | US20060229279 Artemisinins with improved stability and bioavailability for therapeutic drug development and application |
10/12/2006 | US20060229278 Antioxidant: methoxyphenyl alkyl triphenylphosphonium or methoxy dioxocyclohexadiene alkyl triphenylphosphonium derivatives; Parkinson's, Alzheimer's disease, Huntington's Chorea and Friedreich's Ataxia |
10/12/2006 | US20060229256 Enternal administration of arginine and glutamine for abnormal vascular proliferation |
10/12/2006 | US20060229246 Peptide-enhanced transfections |
10/12/2006 | US20060229245 Lyophilized HGF preparations |
10/12/2006 | US20060229239 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis |
10/12/2006 | US20060229238 Sustained release of microcrystalline peptide suspensions |
10/12/2006 | US20060228782 Blood coagulation factor; nucleotide encodes polypeptide; amino acid sequence differs from wild-type FVII or FVIIa; amino acid residue attachment group for non-polypeptide moiety has been introduced or removed; host cell is gammacarboxylating capable of in vivo glycosylation; coagulation disorders |
10/12/2006 | US20060228417 Mucoadhesive composition comprising polyacrylate and chemoattractant |
10/12/2006 | US20060228414 Method for the preparation of controlled release formulations |
10/12/2006 | US20060228407 Enhanced delivery via serpin enzyme complex receptor |
10/12/2006 | US20060228397 Dietary supplement, and methods of use |
10/12/2006 | US20060228396 Arginine-containing compositions and methods for increasing blood flow using same |
10/12/2006 | US20060228395 Vitamin E phosphate/phosphatidylcholine liposomes to protect from or ameliorate cell damage |
10/12/2006 | US20060228385 Sustained release of microcrystalline peptide suspensions |
10/12/2006 | US20060228383 comprising a fluoroether anesthetic compound selected from sevoflurane, desflurane, isoflurane, enflurane and methoxyflurane, and at least one stabilizer agent selected from propylene glycol, polyethylene glycol, hexylene glycol, 1,3-butylene glycol and a saturated cyclic alcohol preferably menthol |
10/12/2006 | US20060228358 Antibody molecules having specificity for human il-1 beta |
10/12/2006 | US20060228345 Osteogenesis promoter |
10/12/2006 | US20060228331 IL-21 Derivatives and variants |
10/12/2006 | US20060226076 Purification of a nonionic solvent, polyethoxylated caster oil, byby running a solution of the solvent in alcohol and water through a chromatography column packed with reverse phase silica; elution; evaporation; stabilizers for injections of anticarcinogenic agents, paclitaxel; storage stability |
10/12/2006 | DE19940944B4 Retardierte, orale, pharmazeutische Darreichungsformen Prolonged-release oral pharmaceutical dosage forms |
10/12/2006 | DE10064219B4 Neue Fentanyl und/oder dessen Derivate enthaltende enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung New fentanyl and / or derivatives thereof containing containing pharmaceutical composition for nasal administration |
10/12/2006 | CA2605386A1 Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye |
10/12/2006 | CA2604599A1 Hydrophilic core polymeric micelles for the delivery of water-soluble compounds |
10/12/2006 | CA2603853A1 Polymeric micelles for drug delivery |
10/12/2006 | CA2603649A1 Buccal delivery system |
10/12/2006 | CA2603347A1 Oil-in-water emulsions of lignans that exhibit improved absorption rate |
10/12/2006 | CA2603245A1 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
10/12/2006 | CA2603016A1 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device |
10/12/2006 | CA2602654A1 Method for shielding functional sites or epitopes on proteins |
10/12/2006 | CA2602231A1 Prevention of hiv-infection |
10/12/2006 | CA2601435A1 A cosmetic composition, a pharmaceutical composition and a process for preparing said compositions |
10/12/2006 | CA2601374A1 Improved formulations of fenofibrate containing menthol or a peg/poloxamer mixture |
10/12/2006 | CA2601372A1 Improved formulations of fenofibrate containing menthol or peg/poloxamer |
10/11/2006 | EP1710307A2 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
10/11/2006 | EP1710304A1 Process for producing polymer composite of protein |
10/11/2006 | EP1710257A1 Hyaluronic acid derivative and drug containing the same |
10/11/2006 | EP1709975A1 Tablet and process for producing the same |
10/11/2006 | EP1709958A1 Seamless filled capsules |
10/11/2006 | EP1709957A2 Sustained-release analgesic compounds |
10/11/2006 | EP1709161A2 Human therapeutic cells secreting nerve growth factor |
10/11/2006 | EP1709084A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins |
10/11/2006 | EP1709083A1 Adenocarcinoma specific antibody sam-6, and uses thereof |
10/11/2006 | EP1709066A1 Inclusion complexes of perindopril |
10/11/2006 | EP1708755A2 Transglutaminase mediated conjugation of peptides |
10/11/2006 | EP1708752A2 Polymer-bound antibody cancer therapeutic agent |
10/11/2006 | EP1708747A2 Non-animal origin stabilizers and processes for producing the same |
10/11/2006 | EP1708742A2 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof |
10/11/2006 | EP1708721A1 Myocardial perfusion imaging using adenosine receptor agonists |
10/11/2006 | EP1708719A2 Aqueous pharmaceutical compositions 2,6-diisopropylphenol (propofol) and their use |
10/11/2006 | EP1708681A1 Cefdinir oral suspension |
10/11/2006 | EP1708679A2 Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin |
10/11/2006 | EP1708676A2 Methods and compositions for facilitating metabolic control |
10/11/2006 | EP1471896B1 Formulations for inhalation |
10/11/2006 | EP1360988B1 Method for dehydrating moist article using a cyclotetrasaccharide |
10/11/2006 | EP1348024B1 Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases |
10/11/2006 | EP1303258B1 Novel aerosol formulation containing a polar fluorinated molecule |
10/11/2006 | EP1276505B1 Mixtures of triblock polyesterpolyethylene glycol copolymers |
10/11/2006 | EP1226212B1 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
10/11/2006 | EP1204630B1 Branched, substantially unsaturated ester oils |
10/11/2006 | EP1128835B9 Cyanocobalamin (vitamin b 12) treatment in allergic disease |
10/11/2006 | EP1107807B1 Use of citrate in a catheter lock solution |
10/11/2006 | EP0982990B1 Stable liquid calcium ascorbate compositions and methods of manufacture and use |
10/11/2006 | EP0842209B1 Multiblock biodegradable hydrogels for use as controlled release agents for drugs and tissue treatment agents |
10/11/2006 | EP0832225B1 Chimeric proteins for use in transport of a selected substance into cells |
10/11/2006 | CN1845938A Polypeptides |
10/11/2006 | CN1845931A Cyclic maltosyl maltose, cyclic maltosyl maltose synthase, method of producing the same and use thereof |
10/11/2006 | CN1845877A Oxidative reductive potential water solution, processes for producing same and methods of using the same |
10/11/2006 | CN1845753A Liquid, aqueous, pharmaceutical compositions of factor vii polypeptides |
10/11/2006 | CN1845742A Method of stabilizing diarylvinylene compound |
10/11/2006 | CN1845722A Granular sustained release preparation and production thereof |
10/11/2006 | CN1845721A Methods for administering aripiprazole |
10/11/2006 | CN1844215A Process for preparing hyaluronic acid-chitosan crosslinked biocompatible materials |
10/11/2006 | CN1844202A Carboxymethyl chitosan nanoparticles as medicine carrier and method for preparing same |
10/11/2006 | CN1844192A Synthesis of ABA polypeptide -b- polytetrahydrofuran-b-polypeptide triblock copolymer |
10/11/2006 | CN1844191A Polytetrahydrofuran and poly-p-dioxanone triblock copolymer and its preparation method and use |
10/11/2006 | CN1844170A Preparation for transgenic carrier of temperature-sensitive poly isopropyl acrylamide and poly arginine conjugate |
10/11/2006 | CN1843902A Meso-porous nanometer particle of calcium phosphate, its preparation method and application |
10/11/2006 | CN1843509A Freeze-drying hepatitis A attenuated live vaccine and its preparation method |
10/11/2006 | CN1843504A Albumin nanosphere medicine composition and its preparation method and application method |
10/11/2006 | CN1843434A Pharmaceutical composition for treating qi and blood deficiency and its preparation method |
10/11/2006 | CN1843363A Externally applied sulfamylonum formulation and its preparation method |
10/11/2006 | CN1843362A Composite vitamin injection and its preparation method |
10/11/2006 | CN1843361A Cefditoren pivoxil dry suspensoid and its preparing process |
10/11/2006 | CN1843360A Slow release injection containing cefradine |
10/11/2006 | CN1843354A Injectable pharmaceutical composition containing faropenem |
10/11/2006 | CN1843352A Mitiglinide calcium formulation formula |
10/11/2006 | CN1843351A Bilobalide B powder injection and its preparing method |
10/11/2006 | CN1843350A Pharmaceutical composition for treating cardiovascular and cerebrovascular disease |
10/11/2006 | CN1843342A Eye medicine for treating fungal keratitis |
10/11/2006 | CN1843337A Felbinac transdermal plaster and its preparation method |
10/11/2006 | CN1843334A Method for promoting liposome encapsulation and its formulation |
10/11/2006 | CN1843333A Sodium hyaluronate carulon fat emulsion formulation and its uses |
10/11/2006 | CN1279165C Inflenza vaccine composition |